ANNA SMALL: Open Payments
NPI 1235172321 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,197 in 64 payments from 18 companies in 2025. Trend: 2023 $539 · 2024 $876 · 2025 $1,197
Food & beverage: $1,197
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $209 |
| PFIZER INC. | 8 | $174 |
| Lilly USA, LLC | 12 | $155 |
| Corcept Therapeutics | 4 | $133 |
| Novo Nordisk Inc | 7 | $122 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Abbott Laboratories | 2 | $54 |
| Phathom Pharmaceuticals, Inc. | 5 | $48 |
| SANOFI-AVENTIS U.S. LLC | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
Products named: VRAYLAR, Korlym, MOUNJARO, PREVNAR 20, ELIQUIS, Ozempic, FREESTYLE LIBRE 3, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
